StockWatch
·

Sedemac Mechatronics Ltd Q2 FY27 Results

SEDEMACQ2 FY27 Results
Filing
Result:Good· Market: Down#Margin squeeze#Broad based#Record quarter

Outlook: Optimistic · Guidance: None

MetricValue (₹ Cr)vs Q1 FY27
Revenue400.6429.3%
Total Income401.2529.2%
Expenditure350.7230.2%
PBT50.5322.2%
Net Profit39.1817.6%
OPM18.86%0.24pp
NPM9.76%0.96pp
EPS8.8717.6%
View full financials

Revenue growth of 39.9% YoY and adjusted PAT growth of 30% were driven broadly by record Mobility/ECU volumes, but margin compression (OPM 18.86% vs 21.32%, NPM 9.78% vs 10.52%) from new-facility finance costs/depreciation plus negative H1 operating cash flow and rising borrowings cap it below very_good.

SEDEMAC MECHATRONICS · Q2 FY-2027 · THE VERDICT

Record Revenue, Margin Reality Check

Sedemac delivered its highest-ever revenue (₹400.6 Cr, +29% QoQ) on strong momentum, but operating profit margin compressed to 18.9% as raw material inflation outpaced pricing power. The core question: Is this a temporary cost headwind, or a structural drag on near-term earnings?

11 Nov 2026 · 6 min read
Revenue

₹400.6 Cr

Highest ever, +29% QoQ

OPM

18.9%

Compressed from RM costs

PAT

₹39.2 Cr

+18% QoQ (lag vs revenue growth)

On paper, a blowout quarter: revenue hit an all-time high of ₹400.6 crore—a 29% quarter-on-quarter surge. But here's the tension: profit growth (18% QoQ) significantly lagged revenue growth (29% QoQ), the telltale signature of margin compression. Operating margin fell to 18.9%, a noticeable dip that management attributed to raw material inflation. The critical question: Is this a temporary cost headwind that will ease as capex moderates and pricing negotiations catch up, or a structural pressure on near-term earnings that will persist?

The operating leverage claim: what holds up

Management's central argument vs. the delivered result

Operating leverage from 40%+ revenue growth is offsetting RM cost increases

Revenue grew 29% QoQ; PAT grew 18% QoQ. OPM fell to 18.9% despite strong absolute revenue. Operating leverage exists but is not offsetting the full RM cost impact.

Partially supported

RM cost inflation impact is 'bit of a dip', not structural

OPM compressed visibly in Q2; management stated RM costs remain elevated. Pricing is negotiated case-by-case, not indexed—no automatic pass-through.

Supported (but not a one-off)

EBITDA will hold H2 vs H1FY27 despite ongoing RM pressure

No H1/H2 breakdown provided in Q2 result. Management guided conservatively on H2 capex being lower, which would help stabilize margins if volumes hold.

Credible but unverified

Where the margin went

Revenue jumped 29% QoQ but PAT rose only 18%, signaling an earnings shortfall of roughly 11 percentage points. Two forces are at work. First: RM cost inflation absorbed by Sedemac rather than passed to customers. Pricing is negotiated on a case-by-case basis, not indexed to commodity prices—a structural disadvantage when material costs spike. Second: Heavy capex spending. Capex surged from ₹227 crore (FY26 full year) to roughly ₹450 crore annualized in H1 FY27, a near-doubling. MF3 plant startup and MF5 land acquisition in Tamil Nadu are consuming cash faster than revenue growth offsets. The mitigating factor: Management guided H2 capex to be "lower than H1," suggesting H2 could see some margin relief as capex moderates relative to revenue.

What changed on this call

Key upgrades and new developments
  • ISG+EFI ramp accelerating: >1 million units shipped in last 8 months (faster than prior-quarter narrative)

  • Commercial vehicle market entry formalized: After-treatment controllers, EFI ECUs, and MCUs entering production next few quarters

  • Power tools market win: Magneto Kit for European 2/3-wheeler OEM; production ramp expected H1 FY28

  • Plant expansion accelerated: MF5 land acquired in Shoolagiri, Tamil Nadu; MF3 pilot production started ahead of schedule

  • Capex cycle strains near-term FCF: H1 run-rate ~₹450 Cr annualized; deleveraging will persist until capex moderates

The bull-bear ledger

  • Highest-ever quarterly revenue; 40%+ recent growth momentum sustained from prior year

  • ISG+EFI milestone (>1M units) validates market adoption and supply chain readiness

  • Three new platforms ramping: commercial vehicles, power tools, sensor-less MCUs—meaningful TAM diversification

  • Management track record solid: No prior guidance misses; delivered on product roadmap and capacity milestones

  • Margin compression is real; RM cost not fully passed through to customers—near-term earnings headwind

  • Capex cycle is heavy: H1 run-rate ~₹450 Cr on ₹400 Cr quarterly revenue (capex intensity >100% of Q2 revenue)

  • Power tools market entry is early-stage and competitive; management candid: 'Nobody knows if we will succeed'

  • EV 2/3-wheeler penetration only 11.4%—core growth thesis hinges on electrification pace, not yet structural

Ranked risks: what should concern a holder

Top-of-mind concerns ordered by severity and holder impact

Raw material cost pressure unabated; pricing negotiated, not indexed

High

OPM fell to 18.9% despite 29% revenue growth. If commodity prices stay elevated and customers resist further price hikes, margin dip persists into H2 and FY28. This is the key near-term earnings drag.

Capex cycle delevering near-term free cash flow

High

Capex ~₹450 Cr annualized vs. ₹227 Cr prior year full year. MF3 and MF5 ramps will absorb cash. Deleveraging and shareholder capital return capacity limited until capex moderates in H2 FY28+.

Power tools market entry is early-stage and highly competitive

Medium

Management acknowledged real uncertainty ('Nobody knows if we will succeed'). Bosch, Denso, Infineon already dominant in motor control. Sedemac's advantage (sensor-less tech) is real but volumes and margins are unproven.

EV 2/3-wheeler penetration still niche (11.4% of market in H1)

Medium

Core thesis hinges on electrification pace. If EV adoption slows or plateaus below forecasts (vehicle-price sensitive market), demand for EV-centric products weakens and ISG+EFI ramp stalls.

Capex execution and cost overrun risk on MF3/MF5

Medium

MF3 and MF5 ramps depend on flawless execution. Delays or cost overruns would strain FCF further and push deleveraging timeline out by 1-2 years.

How the street is reading it

The stock is trading at ₹3093, down 14.27% from its all-time high of ₹3607.8 but still +118.88% above its 52-week low. It's currently trading below its 20-day and 50-day moving averages, signaling near-term technical weakness. The RSI is neutral at 46.9, suggesting no extreme overbought or oversold condition. On the surface, this repricing seems harsh for a record revenue print—but the market is rational to be cautious. Margin compression and heavy capex spending are dimming near-term EPS visibility, even if long-term growth drivers remain intact.

Institutional flows reveal a mixed stance. FII ownership rose 1.75 percentage points to 4.27% in Q1 FY27, a modest positive signal. However, bulk and block deals in the ₹3010 price range tell the real story: A91 Emerging Fund (a growth specialist) sold 16.1 million shares; Xponentia Opportunities Fund sold 9.9 million shares; HDFC Life trimmed positions multiple times. On the flip side, T Rowe Price, Invesco, Franklin Templeton, and the Monetary Authority of Singapore bought. The pattern: global value and sovereign wealth are nibbling on the dip, while domestic growth-focused funds are trimming. This classic divergence signals caution among growth investors and selective bargain-hunting by value investors—a sign that the margin headwind and capex cycle are genuine concerns, not just near-term noise.

The debate

What to watch next (resolve the debate in ~6 months)
  • 1 · Q3 FY27: Margin stabilization signal

    Management guided EBITDA to hold H2 vs H1FY27. If OPM stays at 18-19% in Q3 and RM cost inflation doesn't worsen, the bear case weakens and capex cycle becomes manageable. If OPM dips below 18%, the margin headwind is structural and more severe than guided.

  • 2 · Commercial vehicle & power tools production ramp

    Commercial vehicle launches (after-treatment controller, EFI ECU) and Magneto Kit production both guided for H1 FY28 ramp. If these platforms ship material volumes (>10-15% of quarterly revenue by Q4 FY27), diversification thesis gains traction and reduces ISG+EFI concentration risk. Delays would signal execution risk.

  • 3 · H2 FY27 capex execution vs. guidance

    Management said H2 capex will be "lower than H1." If H2 comes in <₹200 Cr and FCF turns positive (vs. consumed by capex), the cash flow cycle stabilizes. Beats to capex guidance would unlock near-term shareholder return capacity.

Sedemac is not broken—record revenue and ISG+EFI milestone (>1M units) prove genuine market momentum. But Q2 is a yellow flag on near-term earnings. Margin compression, capex absorption, and early-stage new markets (power tools, commercial vehicles) mean the stock has shifted from pure-growth story to 'execution matters' story. The market has already repriced it 14% off the high; the reset is partially justified.

Verdict: Hold on a 'show me' basis. The number to track from here is operating margin in H2 FY27. If OPM holds at 18-19%, the bull thesis survives. If it dips below 18%, the margin problem is structural and downside risk rises. Either way, clarity arrives in 3-4 months.

Informational and educational content only. Not investment advice.